International Journal of Clinical Pharmacy

, Volume 37, Issue 3, pp 485–496 | Cite as

Clinical pharmacy services that influence prescribing in the Western Pacific Region based on the FIP Basel Statements

  • Jonathan PenmEmail author
  • Betty Chaar
  • Rebekah Moles
Research Article


Background Clinical pharmacy services have been associated with decreased mortality rates, length of stay, medication errors, adverse drug reactions and total cost of care. Such services have recently been introduced to the Western Pacific Region (WPR), particularly in Asia. A survey to measure clinical pharmacy services that influence prescribing has been validated in the WPR and can be used to explore the implementation of such services. Objective To explore the implementation of clinical pharmacy services that influence prescribing in the WPR and the barriers and facilitators involved in their implementation. Setting Hospital pharmacies in the WPR. Method Hospital pharmacy directors in the WPR were emailed a link to the validated survey. Surveys were available in English, Japanese, Chinese, Vietnamese, Lao, Khmer, French and Mongolian. Main outcome measure (1) Percentage of hospitals offering clinical pharmacy services. (2) Percentage of in-patients receiving a medication history, review or discharge counselling by a pharmacist. Results In total, 726 responses were received from 31 countries and nations. Nearly all hospitals, 90.6 % (658/726), stated they provided clinical pharmacy services. On average 28 % of their clinical pharmacists attended medical rounds regularly. The median percentage of inpatients receiving a medication history and discharge counselling by a pharmacist was 40 and 30 % respectively. Higher internal facilitator factor scores significantly increased the likelihood of offering clinical services and having pharmacists attend medical rounds regularly. Internal facilitators included individual pharmacist traits and pharmacy departmental structure/resources. Higher environmental facilitator factor scores and having a higher percentage of pharmacists attend medical rounds regularly significantly increased the likelihood of inpatients receiving a medication history, a medication review and discharge counselling by a pharmacist. Environment facilitators included government support, patient and physician expectations. Conclusion A large proportion of hospitals in the WPR have implemented clinical pharmacy services. Although internal facilitators were shown to be important for initiating such services, the addition of environmental facilitators and ward round participation by pharmacists allowed clinical services to be integrated throughout the hospitals.


Basel Statements Clinical pharmacy services Hospital pharmacy Western Pacific Region 



We would like to acknowledge the help of the following groups for aiding us distribute the survey: Chinese Pharmaceutical Association, Food and Drug Department, Ministry of Health, Lao People’s Democratic Republic, Hong Kong Hospital Authority, Japanese Society of Hospital Pharmacists, Korean Society of Health-System Pharmacists, New Zealand Hospital Pharmacists’ Association, Pharmaceutical Services Division, Ministry of Health Malaysia, Pharmaceutical Society of Papua New Guinea, Philippine Society of Hospital Pharmacists, Society of Hospital Pharmacists of Australia, Taiwan Society of Health-System Pharmacists. All those that participated in the study.


This work was supported by a grant from the International Pharmaceutical Federation Hospital Pharmacy Section.

Conflicts of interest

The authors declare no conflict of interest.


  1. 1.
    World Health Organization. Continuity and change: implementing the third WHO medicines strategy 2008–2013. Geneva: WHO Press; 2010.Google Scholar
  2. 2.
    O’Connor MN, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29(6):437–52.CrossRefPubMedGoogle Scholar
  3. 3.
    World Health Organization. Medicines: rational use of medicines. Fact sheet number 338. Geneva: WHO Media centre; 2010.Google Scholar
  4. 4.
    Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27(4):481–93.CrossRefPubMedGoogle Scholar
  5. 5.
    Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing. Pharmacotherapy. 2001;21(2):129–41.CrossRefPubMedGoogle Scholar
  6. 6.
    Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy. 2002;22(2):134–47.CrossRefPubMedGoogle Scholar
  7. 7.
    Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherapy. 2006;26(6):735–47.CrossRefPubMedGoogle Scholar
  8. 8.
    Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy. 2000;20(6):609–21.CrossRefPubMedGoogle Scholar
  9. 9.
    Kwan JL, Lo L, Sampson M, Shojania KG. Medication reconciliation during transitions of care as a patient safety strategy: a systematic review. Ann Intern Med. 2013;158(5 Pt 2):397–403.CrossRefPubMedGoogle Scholar
  10. 10.
    Bobb A, Gleason K, Husch M, Feinglass J, Yarnold PR, Noskin GA. The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. Arch Intern Med. 2004;164(7):785–92.CrossRefPubMedGoogle Scholar
  11. 11.
    Touchette D, Doloresco F, Suda K, Perez A, Turner S, Jalundhwala Y, et al. Economic evaluations of clinical pharmacy services: 2006–2010. Pharmacotherapy. 2014;34(8):771–93.CrossRefPubMedGoogle Scholar
  12. 12.
    De Rijdt T, Willems L, Simoens S. Economic effects of clinical pharmacy interventions: a literature review. Am J Health Syst Pharm. 2008;65(12):1161–72.CrossRefPubMedGoogle Scholar
  13. 13.
    The Basel Statements on the future of hospital pharmacy. Am J Health Syst Pharm. 2009;66(Suppl 3):S61–6.Google Scholar
  14. 14.
    Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing—2010. Am J Health Syst Pharm. 2011;68(8):669–88.CrossRefPubMedGoogle Scholar
  15. 15.
    Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: dispensing and administration—2011. Am J Health Syst Pharm. 2012;69(9):768–85.CrossRefPubMedGoogle Scholar
  16. 16.
    Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education—2012. Am J Health Syst Pharm. 2013;70(9):787–803.CrossRefPubMedGoogle Scholar
  17. 17.
    Hall K, Wilgosh C. Hospital pharmacy in Canada 2011/2012 report. Toronto: Eli Lily Canada; 2013.Google Scholar
  18. 18.
    Frontini R, Miharija-Gala T, Sykora J. EAHP survey 2010 on hospital pharmacy in Europe: parts 4 and 5. Clinical services and patient safety. Eur J Hosp Pharm. 2013;20:69–73.Google Scholar
  19. 19.
    Penm J, Li Y, Zhai S, Hu Y, Chaar B, Moles R. The impact of clinical pharmacy services in China on the quality use of medicines: A systematic review in the context of China’s current healthcare reform. Health Policy Plan. 2013;29(7):849–72.CrossRefPubMedGoogle Scholar
  20. 20.
    Penm J, Moles R, Wang H, Li Y, Chaar B. Factors affecting the implementation of clinical pharmacy services in China. Qual Health Res. 2014;24(3):345–56.CrossRefPubMedGoogle Scholar
  21. 21.
    Zhang C, Zhang L, Huang L, Luo R, Wen J. Clinical pharmacists on medical care of pediatric inpatients: a single-center randomized controlled trial. PLoS One. 2012;7(1):e30856.CrossRefPubMedCentralPubMedGoogle Scholar
  22. 22.
    Shen J, Sun Q, Zhou X, Wei Y, Qi Y, Zhu J, et al. Pharmacist interventions on antibiotic use in inpatients with respiratory tract infections in a Chinese hospital. Int J Clin Pharm. 2011;33(6):929–33.CrossRefPubMedGoogle Scholar
  23. 23.
    Rutter V, Wong C, Coombes I, Cardiff L, Duggan C, Yee M-L, et al. Use of a general level framework to facilitate performance improvement in hospital pharmacists in Singapore. Am J Pharm Educ. 2012;76(6):107.CrossRefPubMedCentralPubMedGoogle Scholar
  24. 24.
    Chan A, Shih V, Chiang J, Chew L, Tay K, Quek R, et al. Clinical pharmacy services and research for lymphoma patients at a cancer center. J Oncol Pharm Pract. 2013;19(1):24–30.CrossRefPubMedGoogle Scholar
  25. 25.
    Wang HY, Chan ALF, Chen MT, Liao CH, Tian YF. Effects of pharmaceutical care intervention by clinical pharmacists in renal transplant clinics. Transplant Proc. 2008;40(7):2319–23.CrossRefPubMedGoogle Scholar
  26. 26.
    Wang KY, Chian CF, Lai HR, Tarn YH, Wu CP. Clinical pharmacist counseling improves outcomes for Taiwanese asthma patients. Pharm World Sci. 2010;32(6):721–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Chung JST, Lee KKC, Tomlinson B, Lee VWY. Clinical and economic impact of clinical pharmacy service on hyperlipidemic management in Hong Kong. J Cardiovasc Pharmacol Ther. 2011;16(1):43–52.CrossRefPubMedGoogle Scholar
  28. 28.
    World Health Organization. Western Pacific country health information profiles 2011 revision. Geneva: WHO Press; 2011.Google Scholar
  29. 29.
    Penm J, Chaar B, Dechun J, Moles R. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements. Am J Health Syst Pharm. 2013;70(11):967–79.CrossRefPubMedGoogle Scholar
  30. 30.
    Penm J, Chaar B, Rose G, Moles R. Pharmacists’ influences on prescribing: validating a clinical pharmacy services survey in the Western Pacific Region. Res Social Adm Pharm. 2015;11(1):63–73.CrossRefPubMedGoogle Scholar
  31. 31.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.PubMedGoogle Scholar
  32. 32.
    Krejcie RV, Morgan DW. Determining sample size for research activities. Educ Psychol Meas. 1970;30(3):607–10.Google Scholar
  33. 33.
    World Health Organization. District health facilities: guidelines for development & operations. Geneva: WHO Press; 1998.Google Scholar
  34. 34.
    Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–91.CrossRefPubMedGoogle Scholar
  35. 35.
    Leplège A, Sally Verdier A, Shumaker A, Berzon Richard A. The adaptation of health status measures: methodological aspects of the translation procedure. Oxford: Rapid Communications; 1995.Google Scholar
  36. 36.
    Gupta SR, Wojtynek JE, Walton SM, Botticelli JT, Shields KL, Quad JE, et al. Association between hospital size and pharmacy department productivity. Am J Health Syst Pharm. 2007;64(9):937–44.CrossRefPubMedGoogle Scholar
  37. 37.
    Moles R, Brien J-A, Benrimoj C. Factors Influencing pharmaceutical service provision within NSW private hospitals. Aust Pharm. 2004;23(3):238–43.Google Scholar
  38. 38.
    Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education—2009. Am J Health Syst Pharm. 2010;67(7):542–58.CrossRefPubMedGoogle Scholar
  39. 39.
    Poh EW, Nigro O, Avent ML, Doecke CJ. Pharmaceutical Reforms: clinical pharmacy ward service versus a medical team model. J Pharm Pract Res. 2009;39(3):176–80.CrossRefGoogle Scholar
  40. 40.
    Haas CE, Eckel S, Arif S, Beringer PM, Blake EW, Lardieri AB, et al. Acute care clinical pharmacy practice: unit- versus service-based models. Pharmacotherapy. 2012;32(2):e35–44.CrossRefPubMedGoogle Scholar
  41. 41.
    Bond CA, Raehl CL, Patry R. Evidence-based core clinical pharmacy services in United States hospitals in 2020: services and staffing. Pharmacotherapy. 2004;24(4):427–40.CrossRefPubMedGoogle Scholar
  42. 42.
    Yiu HY, Chien WT, Lui MH, Qin B. Information needs of Chinese surgical patients on discharge: a comparison of patients’ and nurses’ perceptions. J Adv Nurs. 2011;67(5):1041–52.CrossRefPubMedGoogle Scholar
  43. 43.
    Thompson CA. Pharmacy practice models get improved. Am J Health Syst Pharm. 2011;68(9):774–83.CrossRefPubMedGoogle Scholar
  44. 44.
    Ronis A, Higgins G, Wheatley W, Payton J, Wem M, Maunsell T, et al. SHPA standards of practice for the community liaison pharmacist. Aust J Hosp Pharm. 1996;26(5):570–2.Google Scholar
  45. 45.
    Knoer SJ, Pastor JD III, Phelps PK. Lessons learned from a pharmacy practice model change at an academic medical center. Am J Health Syst Pharm. 2010;67(21):1862–9.CrossRefPubMedGoogle Scholar
  46. 46.
    Gums JG. Changing the direction of clinical pharmacy outside the United States: time to step up. Pharmacotherapy. 2013;33(2):122–5.CrossRefPubMedGoogle Scholar
  47. 47.
    Scott A, Jeon SH, Joyce CM, Humphreys JS, Kalb G, Witt J, et al. A randomised trial and economic evaluation of the effect of response mode on response rate, response bias, and item non-response in a survey of doctors. BMC Med Res Methodol. 2011;11(126):1–12.Google Scholar
  48. 48.
    Denscombe M. Item non-response rates: a comparison of online and paper questionnaires. Int J Soc Res Methodol. 2009;12(4):281–91.CrossRefGoogle Scholar

Copyright information

© Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie 2015

Authors and Affiliations

  1. 1.World Hospital Pharmacy Research Consortium (WHoPReC)The University of SydneyCamperdownAustralia

Personalised recommendations